MedTrace Logo

Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations

NCT00763841 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2010-01-20

No results posted yet for this study

Summary

Transcranial magnetic stimulation (TMS) involves the use of magnetic fields to non-invasively stimulate the brain. Studies overseas have suggested this may be an effective and safe treatment for auditory hallucinations in patients with schizophrenia. This is a sham-controlled, double-blind trial of TMS stimulation for the treatment of auditory hallucinations in patients with schizophrenia.

Conditions

  • Auditory Hallucinations

Interventions

DEVICE

Transcranial magnetic stimulation

Stimulation will be given daily at a particular site for three days a week

DEVICE

Sham

Sponsors & Collaborators

  • NSW Schizophrenia Fellowship

    collaborator UNKNOWN

  • Rebecca Cooper Medical Research Foundation

    collaborator UNKNOWN

  • The University of New South Wales

    lead OTHER

Principal Investigators

  • Colleen Loo, MBBS, FRANZCP. MD · University of NSW

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00763841 on ClinicalTrials.gov